The JUUL E-Cigarette Elevates the Risk of Thrombosis and Potentiates Platelet Activation

Jean E.Montes Ramirez, Zubair A. Karim, Ahmed B. Alarabi, Keziah R. Hernandez, Ziyad Ben Taleb, José O. Rivera, Fadi T. Khasawneh, Fatima Z. Alshbool

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


Background: Smoking is the main preventable cause of death in the United States and worldwide and is associated with serious cardiovascular health consequences, including thrombotic diseases. Recently, electronic cigarettes (e-cigarettes) and, in particular JUUL, have attained wide popularity among smokers, nonsmokers, pregnant females, and even the youth, which is alarming. Interestingly, there is/are no information/studies regarding the effect of JUUL on cardiovascular diseases, specifically in the context of modulation of platelet activation. Thus, it is important to discern the cardiovascular disease health risks associated with JUUL. Methods and Results: We used a passive e-vape vapor inhalation system where C57BL/6J mice (10-12 weeks old) were exposed to JUUL e-cigarette vape. Menthol flavored JUUL pods containing 5% nicotine by weight were used as the e-liquid. Mice were exposed to a total of 70 puffs daily for 2 weeks; 3-second puff duration, and 25-second puff interval. The effects of JUUL relative to clean air were analyzed, on mouse platelet function in vitro (eg, aggregation) and in vivo (eg, FeCl3-induced carotid artery injury thrombosis model). Our results indicate that short-term exposure to JUUL e-cigarette causes hyperactivation of platelets and shortens the thrombus occlusion as well as hemostasis/bleeding times, relative to clean air (medians of 14 vs. 200 seconds, P <.01 and 35 vs. 295 seconds, P <.001, respectively). Conclusion: Our findings document—for the first time—that short-term exposure to the JUUL e-cigarette increases the risk of thrombotic events, in part by modulating platelet function, such as aggregation and secretion, in mice.

Original languageEnglish (US)
Pages (from-to)578-586
Number of pages9
JournalJournal of Cardiovascular Pharmacology and Therapeutics
Issue number6
StatePublished - Nov 1 2020
Externally publishedYes


  • JUUL
  • cardiovascular disease
  • e-cigarettes
  • platelets
  • thrombosis
  • vaping

ASJC Scopus subject areas

  • Pharmacology
  • Cardiology and Cardiovascular Medicine
  • Pharmacology (medical)


Dive into the research topics of 'The JUUL E-Cigarette Elevates the Risk of Thrombosis and Potentiates Platelet Activation'. Together they form a unique fingerprint.

Cite this